In this issue:
Olaparib maintenance may be beneficial in all HRD platinum-sensitive disease
Risk of secondary MDS/AML following PARP inhibitor therapy
RRS with delayed oophorectomy improves QoL in BRCA mutation carriers
Is hysterectomy beneficial for women with BOTs?
TRU-D: Dual immunotherapy + neoadjuvant chemo promising for advanced disease
Inhibition of AKT1 may render SOX2-positive ovarian cancer platinum-sensitive
Nanoparticle-mediated TP53 restoration promising for ovarian cancer
A new risk model based on immune and stromal related signatures
Please login below to download this issue (PDF)